During prostate screening, elevated prostate-specific antigen (PSA) levels indicate an increased risk of PCa; however, PSA is organ-specific but not tumor-specific, and the specificity of PSA in reflecting disease severity remains debatable (5). The gene discussed is KLK3; the disease is posterior cortical atrophy.